Platelet Rich Plasma (PRP) as a Treatment for ACHILLES Tendon Tears

Achilles Tendon Tear Clinical Trial

Official title: PRP as a Treatment for ACHILLES Tendon Tears - Randomized-Double-Blind-Placebo Control Trail

Status Completed

Clinical Trial Summary

To review the influence of patient derived PRGF on the healing process of Achilles tendon after a surgical correction of a complete tear.

Clinical Trial Description

Autologous platelet-rich matrices may aid in post surgical patients by promoting and accelerating tissue healing because of the release of growth factors including transforming growth factor (TGF)-beta1 and platelet-derived growth factor (PDGF) from platelet alpha-granules. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Achilles Tendon Tear

• NCT number: NCT00731068
• Study type: Interventional
• Source: Meir Medical Center
• Status: Completed
• Phase: Phase 2/Phase 3
• Start date: February 2007
• Completion date: March 2009